Evaluation of the effect of Echinacea syrup on outcome in lower of respiratory infections of COVID-19
Phase 3
Recruiting
- Conditions
- Covid-19.Multisystem inflammatory syndrome associated with COVID-19, unspecifiedU10.9
- Registration Number
- IRCT20130522013423N2
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
Definitive diagnosis of Covid 19
Willingness to participate
Evidence of symptoms of lower respiratory infections
Exclusion Criteria
Having underlying diseases such as COPD
deformity in the chest
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptoms of the infection in the lower respiratory tract. Timepoint: Before and after hospitalization. Method of measurement: Procalcitonin test, chest x-ray.
- Secondary Outcome Measures
Name Time Method Duration of hospitalization. Timepoint: After discharge. Method of measurement: Determining hospitalization days using patient record.;Re-hospitalization. Timepoint: After discharge. Method of measurement: Number of readmission times.